These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8116453)

  • 1. Pharmacokinetic study of bisaramil in man.
    Gémesi L; Kapás M; Matos L
    Acta Pharm Hung; 1993 Nov; 63(6):327-33. PubMed ID: 8116453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia.
    Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Mar; 233(1):1-6. PubMed ID: 8472737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and plasma protein binding of the new potent class III antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate.
    Chen CL; Sangiah S; Roder JD; Chen H; Berlin KD; Garrison GL; Scherlag BJ; Lazzara R
    Arzneimittelforschung; 1995 Jun; 45(6):670-5. PubMed ID: 7646568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of bisaramil and its metabolite in plasma using high-performance liquid chromatography with electrochemical detection.
    Matsushima E; Sato T
    J Chromatogr; 1992 Jan; 573(2):339-44. PubMed ID: 1601972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of bisaramil on experimental arrhythmias.
    Paróczai M; Kárpáti E; Solti F
    Pharmacol Res; 1990; 22(4):463-80. PubMed ID: 2402479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tonic and use-dependent block of sodium currents in isolated cardiac myocytes by bisaramil.
    Pugsley MK; Saint DA
    Br J Pharmacol; 1995 Jan; 114(2):377-82. PubMed ID: 7881737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological actions of a new antiarrhythmic drug, bisaramil, on isolated heart preparations.
    Paroczai M; Karpati E; Marko R; Kecskemeti V
    Pharmacol Res; 1992 Jan; 25(1):75-85. PubMed ID: 1738760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic method for quantitative determination of Yutac, a new antiarrhythmic agent, in dog plasma.
    Rónai-Lukács S; Kozma M; Vereczkey L
    J Chromatogr; 1985 Mar; 338(2):428-32. PubMed ID: 3998028
    [No Abstract]   [Full Text] [Related]  

  • 9. Repeated dose pharmacokinetics of pancopride in human volunteers.
    Salva P; Costa J; Pérez-Campos A; Martínez-Tobed A
    Biopharm Drug Dispos; 1994 Nov; 15(8):643-51. PubMed ID: 7888596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisaramil and antiarrhythmics as inhibitors of free radical generation.
    Paróczai M; Röth E; Kárpáti E
    Pharmacol Res; 1997 Apr; 35(4):279-85. PubMed ID: 9264043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of bisaramil and antiarrhythmics on free radical generation of isolated neutrophil granulocytes.
    Lantos J; Röth E; Paróczai M; Kárpáti E
    Acta Chir Hung; 1997; 36(1-4):186-7. PubMed ID: 9408340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose pharmacokinetics and tolerance of pancopride in healthy volunteers.
    Dewland P; Pérez Campos A; Martinez-Tobed A
    Arzneimittelforschung; 1995 Feb; 45(2):177-83. PubMed ID: 7710444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and pharmacokinetics of Ro 42-1611 (arteflene) in man.
    Weidekamm E; Dumont E; Jaquet C
    Trop Med Parasitol; 1994 Sep; 45(3):278-83. PubMed ID: 7899804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal pharmacokinetics and metabolism of the new antimalarial Ro 42-1611 (arteflene).
    Girometta MA; Jauch R; Ponelle C; Guenzi A; Wiegand-Chou RC
    Trop Med Parasitol; 1994 Sep; 45(3):272-7. PubMed ID: 7899803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative analysis of bencynonate in human plasma using a deuterated internal standard by GC-MS/SIM].
    Liu F; Hu XY; Li QY
    Yao Xue Xue Bao; 1994; 29(10):778-84. PubMed ID: 7871998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical management of arrhythmias; newer antiarrhythmic drugs].
    Yamashita T; Sugimoto T
    Nihon Rinsho; 1991 Nov; 49(11):2680-6. PubMed ID: 1685198
    [No Abstract]   [Full Text] [Related]  

  • 17. [Amiodarone absorption and elimination after oral and intravenous administration in healthy individuals].
    Gaete LE; Ortiz M; Soto J; Saavedra I
    Rev Med Chil; 1995 Jun; 123(6):713-9. PubMed ID: 8525224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.
    Trenk D; Wagner F; Sachs W; Jähnchen E
    Eur J Clin Pharmacol; 1989; 37(3):313-6. PubMed ID: 2612546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization.
    Le Coz F; Funck-Brentano C; Morell T; Ghadanfar MM; Jaillon P
    Clin Pharmacol Ther; 1995 May; 57(5):533-42. PubMed ID: 7768076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of bencynonate in human plasma using a deuterated internal standard by gas chromatography-mass spectrometry with selected-ion monitoring.
    Liu F; Hu X; Li Q
    J Chromatogr B Biomed Appl; 1994 Dec; 662(1):123-7. PubMed ID: 7894685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.